The legal framework applicable to biosimilars in the EU
Biosimilars are becoming increasingly important in the European Union’s biopharmaceutical…
Biosimilars are becoming increasingly important in the European Union’s biopharmaceutical landscape due to the increased growth of biologicals as key therapies and the financial pressure this puts on healthcare budgets.